Daniel Virnich, CEO of Starling Oncology STLN, has filed 1 purchase and 0 sales on the open market. The latest trade was on 05/21.

DV

DV

Daniel Virnich

CEO

Company

Starling Oncology STLN

First filing

23/03/21

Trades

22 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Starling OncologySTLN	Open-market buy	25/03/26	25/03/28	22,640 sh	$1.04	$23,545.6	+3.2%